Document Basket

Saved pages

Saved documents

Please note: This information is saved in a cookie. In case your browser deletes cookies after a session, the information will be lost.

DKSH launches Hiruscar® Post Acne in Indonesia December 12, 2019


			
				DKSH launches Hiruscar® Post Acne in Indonesia

DKSH, through its Consumer Goods and Pharmaceutical subsidiary partner PT Wicaksana and its field marketing partner DSFM, launches Hiruscar® Post Acne to contribute to Indonesian medical community.

Media release 

DKSH launches Hiruscar® Post Acne in Indonesia

DKSH, through its Consumer Goods and Pharmaceutical subsidiary partner PT Wicaksana and its field marketing partner DSFM, launches Hiruscar® Post Acne to contribute to Indonesian medical community.

Jakarta, Indonesia, December 12, 2019 – DKSH Business Unit Healthcare, a leading partner for healthcare companies seeking to grow their business in Asia, through its Indonesian partner PT Wicaksana Overseas International Tbk., is bringing its well-known therapeutic skincare product, Hiruscar Post Acne, to the Indonesian market. Hiruscar Post Acne, formulated by Medinova, Switzerland, is specifically designed to address acne scars and dark marks.

 

The Hiruscar Post Acne has a unique formulation that works by smoothing the appearance of acne scars while lightening dark marks, all of which are known to be major concerns among Indonesian consumers with acne-prone skin. Its gel formulation is non-oily, non-comedogenic, hypoallergenic as well as alcohol-free and is suitable for all skin types. Targeted to young Indonesian females aged between 17 and 25 years, Hiruscar Post Acne will be sold through both traditional distribution channels and modern pharmacies. The products aim to reach Indonesia’s main provinces in Jabodetabek, including Jakarta, Bogor, Depok, Tangerang and Bekasi, and Surabaya, East Java in the first quarter of 2020, with plans to expand to more cities across Indonesia.

 

DKSH Smollan Field Marketing (DSFM), the joint venture between DKSH and Smollan, accompanies this exciting launch by supporting the market penetration through offline field marketing efforts. DSFM ensures the products’ sales performance across all channels. The collaboration between DKSH, DSFM and PT Wickasana strengthens the long-standing contribution of the three companies to healthcare in Asia.

 

“Hiruscar Post Acne is brought to Indonesia, as there is an unmet need for over-the-counter products specifically treating acne scars and dark spots. This new product demonstrates DKSH’s focus on contributing to the healthcare sector in Indonesia”, said Alex WY Loh, Assistant General Manager, Business Unit Healthcare, DKSH Indonesia.

 

About Wicaksana

Established in 1973, Wicaksana is a distribution company which distributes fast moving consumer goods, personal care and pharmaceutical products. To distribute all its clients’ products, Wicaksana operates a network of 50 distribution centers scattered across all major cities in Indonesia. Wicaksana recorded net sales of IDR 972 billion in 2018.

 

For more information about Wicaksana, please check: http://wicaksana.co.id/